Share Price and Basic Stock Data
Last Updated: March 22, 2025, 9:43 pm
PEG Ratio | 6.25 |
---|
Competitors of Hindustan Zinc Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Hindustan Zinc Ltd | 1,88,618 Cr. | 446 | 808/290 | 20.0 | 18.1 | 6.50 % | 46.2 % | 55.2 % | 2.00 |
Industry Average | 188,618.00 Cr | 446.00 | 20.00 | 18.10 | 6.50% | 46.20% | 55.20% | 2.00 |
Quarterly Result
Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 7,990 | 8,797 | 9,387 | 8,336 | 7,866 | 8,509 | 7,282 | 6,792 | 7,310 | 7,550 | 8,130 | 8,242 | 8,556 |
Expenses | 3,620 | 3,834 | 4,249 | 3,928 | 4,159 | 4,250 | 3,934 | 3,653 | 3,790 | 3,896 | 4,179 | 4,138 | 4,098 |
Operating Profit | 4,370 | 4,963 | 5,138 | 4,408 | 3,707 | 4,259 | 3,348 | 3,139 | 3,520 | 3,654 | 3,951 | 4,104 | 4,458 |
OPM % | 55% | 56% | 55% | 53% | 47% | 50% | 46% | 46% | 48% | 48% | 49% | 50% | 52% |
Other Income | 279 | 277 | 310 | 367 | 349 | 356 | 287 | 231 | 305 | 280 | 277 | 185 | 221 |
Interest | 50 | 66 | 44 | 51 | 62 | 176 | 218 | 232 | 243 | 262 | 256 | 319 | 285 |
Depreciation | 741 | 816 | 731 | 798 | 807 | 928 | 801 | 825 | 904 | 936 | 843 | 875 | 903 |
Profit before tax | 3,858 | 4,358 | 4,673 | 3,926 | 3,187 | 3,511 | 2,616 | 2,313 | 2,678 | 2,736 | 3,129 | 3,095 | 3,491 |
Tax % | 30% | 33% | 34% | 32% | 32% | 26% | 25% | 25% | 24% | 25% | 25% | 26% | 24% |
Net Profit | 2,701 | 2,929 | 3,093 | 2,681 | 2,157 | 2,589 | 1,970 | 1,737 | 2,038 | 2,042 | 2,358 | 2,298 | 2,647 |
EPS in Rs | 6.39 | 6.93 | 7.32 | 6.35 | 5.10 | 6.13 | 4.66 | 4.11 | 4.82 | 4.83 | 5.58 | 5.44 | 6.26 |
Last Updated: February 28, 2025, 7:29 pm
Below is a detailed analysis of the quarterly data for Hindustan Zinc Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is ₹8,556.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,242.00 Cr. (Sep 2024) to ₹8,556.00 Cr., marking an increase of ₹314.00 Cr..
- For Expenses, as of Dec 2024, the value is ₹4,098.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4,138.00 Cr. (Sep 2024) to ₹4,098.00 Cr., marking a decrease of 40.00 Cr..
- For Operating Profit, as of Dec 2024, the value is ₹4,458.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,104.00 Cr. (Sep 2024) to ₹4,458.00 Cr., marking an increase of ₹354.00 Cr..
- For OPM %, as of Dec 2024, the value is 52.00%. The value appears strong and on an upward trend. It has increased from 50.00% (Sep 2024) to 52.00%, marking an increase of 2.00%.
- For Other Income, as of Dec 2024, the value is ₹221.00 Cr.. The value appears strong and on an upward trend. It has increased from 185.00 Cr. (Sep 2024) to ₹221.00 Cr., marking an increase of ₹36.00 Cr..
- For Interest, as of Dec 2024, the value is ₹285.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 319.00 Cr. (Sep 2024) to ₹285.00 Cr., marking a decrease of 34.00 Cr..
- For Depreciation, as of Dec 2024, the value is ₹903.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 875.00 Cr. (Sep 2024) to ₹903.00 Cr., marking an increase of ₹28.00 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹3,491.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,095.00 Cr. (Sep 2024) to ₹3,491.00 Cr., marking an increase of ₹396.00 Cr..
- For Tax %, as of Dec 2024, the value is 24.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Sep 2024) to 24.00%, marking a decrease of 2.00%.
- For Net Profit, as of Dec 2024, the value is ₹2,647.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,298.00 Cr. (Sep 2024) to ₹2,647.00 Cr., marking an increase of ₹349.00 Cr..
- For EPS in Rs, as of Dec 2024, the value is 6.26. The value appears strong and on an upward trend. It has increased from 5.44 (Sep 2024) to 6.26, marking an increase of 0.82.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 7, 2025, 8:06 pm
Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 12,700 | 13,636 | 14,788 | 14,181 | 17,273 | 22,082 | 21,118 | 18,561 | 22,629 | 29,440 | 34,098 | 28,934 | 32,478 |
Expenses | 6,172 | 6,717 | 7,338 | 7,923 | 7,534 | 9,812 | 10,448 | 9,691 | 10,957 | 13,214 | 16,577 | 15,253 | 16,311 |
Operating Profit | 6,528 | 6,919 | 7,450 | 6,258 | 9,739 | 12,270 | 10,670 | 8,870 | 11,672 | 16,226 | 17,521 | 13,681 | 16,167 |
OPM % | 51% | 51% | 50% | 44% | 56% | 56% | 51% | 48% | 52% | 55% | 51% | 47% | 50% |
Other Income | 1,966 | 1,881 | 2,788 | 3,127 | 2,474 | 1,956 | 1,782 | 1,911 | 1,819 | 1,082 | 1,373 | 1,083 | 963 |
Interest | 27 | 45 | 24 | 17 | 202 | 246 | 113 | 112 | 386 | 290 | 333 | 955 | 1,122 |
Depreciation | 647 | 785 | 644 | 745 | 1,811 | 1,483 | 1,883 | 2,279 | 2,531 | 2,917 | 3,264 | 3,466 | 3,557 |
Profit before tax | 7,820 | 7,970 | 9,570 | 8,623 | 10,200 | 12,497 | 10,456 | 8,390 | 10,574 | 14,101 | 15,297 | 10,343 | 12,451 |
Tax % | 12% | 13% | 15% | 5% | 18% | 26% | 24% | 19% | 25% | 32% | 31% | 25% | |
Net Profit | 6,899 | 6,905 | 8,178 | 8,175 | 8,316 | 9,276 | 7,956 | 6,805 | 7,980 | 9,630 | 10,520 | 7,787 | 9,345 |
EPS in Rs | 16.33 | 16.34 | 19.35 | 19.35 | 19.68 | 21.95 | 18.83 | 16.11 | 18.89 | 22.79 | 24.90 | 18.43 | 22.11 |
Dividend Payout % | 19% | 21% | 23% | 144% | 149% | 36% | 106% | 102% | 113% | 79% | 303% | 71% |
YoY Net Profit Growth
Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 0.09% | 18.44% | -0.04% | 1.72% | 11.54% | -14.23% | -14.47% | 17.27% | 20.68% | 9.24% | -25.98% |
Change in YoY Net Profit Growth (%) | 0.00% | 18.35% | -18.47% | 1.76% | 9.82% | -25.77% | -0.24% | 31.73% | 3.41% | -11.43% | -35.22% |
Hindustan Zinc Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 8% |
5 Years: | 7% |
3 Years: | 9% |
TTM: | 9% |
Compounded Profit Growth | |
---|---|
10 Years: | 3% |
5 Years: | 0% |
3 Years: | 0% |
TTM: | 13% |
Stock Price CAGR | |
---|---|
10 Years: | 11% |
5 Years: | 26% |
3 Years: | 13% |
1 Year: | 51% |
Return on Equity | |
---|---|
10 Years: | 25% |
5 Years: | 29% |
3 Years: | 39% |
Last Year: | 55% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 14, 2024, 11:34 pm
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 845 | 845 | 845 | 845 | 845 | 845 | 845 | 845 | 845 | 845 | 845 | 845 | 845 |
Reserves | 31,431 | 36,573 | 42,508 | 36,540 | 29,960 | 35,087 | 32,760 | 39,465 | 31,468 | 33,437 | 12,097 | 14,388 | 6,797 |
Borrowings | 0 | 0 | 0 | 0 | 7,908 | 0 | 2,538 | 611 | 7,201 | 2,844 | 11,881 | 8,722 | 14,016 |
Other Liabilities | 3,190 | 4,259 | 5,639 | 15,810 | 13,082 | 7,000 | 6,315 | 6,054 | 6,213 | 7,545 | 10,631 | 9,949 | 10,878 |
Total Liabilities | 35,465 | 41,677 | 48,992 | 53,195 | 51,795 | 42,932 | 42,458 | 46,975 | 45,727 | 44,671 | 35,454 | 33,904 | 32,536 |
Fixed Assets | 8,484 | 9,147 | 9,446 | 10,385 | 9,993 | 11,302 | 14,778 | 16,469 | 16,808 | 17,396 | 17,620 | 18,055 | 17,657 |
CWIP | 1,082 | 1,541 | 2,005 | 2,428 | 3,071 | 3,220 | 2,254 | 2,489 | 1,922 | 2,075 | 2,107 | 1,529 | 2,567 |
Investments | 14,540 | 22,506 | 27,254 | 35,221 | 23,783 | 20,222 | 19,488 | 20,329 | 12,957 | 15,052 | 10,107 | 10,452 | 8,437 |
Other Assets | 11,360 | 8,482 | 10,288 | 5,161 | 14,948 | 8,188 | 5,938 | 7,688 | 14,040 | 10,148 | 5,620 | 3,868 | 3,875 |
Total Assets | 35,465 | 41,677 | 48,992 | 53,195 | 51,795 | 42,932 | 42,458 | 46,975 | 45,727 | 44,671 | 35,454 | 33,904 | 32,536 |
Below is a detailed analysis of the balance sheet data for Hindustan Zinc Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹845.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹845.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹6,797.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹14,388.00 Cr. (Mar 2024) to ₹6,797.00 Cr., marking a decrease of 7,591.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹14,016.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from ₹8,722.00 Cr. (Mar 2024) to ₹14,016.00 Cr., marking an increase of 5,294.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹10,878.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹9,949.00 Cr. (Mar 2024) to ₹10,878.00 Cr., marking an increase of 929.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹32,536.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹33,904.00 Cr. (Mar 2024) to ₹32,536.00 Cr., marking a decrease of 1,368.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹17,657.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹18,055.00 Cr. (Mar 2024) to ₹17,657.00 Cr., marking a decrease of 398.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹2,567.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,529.00 Cr. (Mar 2024) to ₹2,567.00 Cr., marking an increase of 1,038.00 Cr..
- For Investments, as of Sep 2024, the value is ₹8,437.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹10,452.00 Cr. (Mar 2024) to ₹8,437.00 Cr., marking a decrease of 2,015.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹3,875.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹3,868.00 Cr. (Mar 2024) to ₹3,875.00 Cr., marking an increase of 7.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹32,536.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹33,904.00 Cr. (Mar 2024) to ₹32,536.00 Cr., marking a decrease of 1,368.00 Cr..
However, the Borrowings (14,016.00 Cr.) are higher than the Reserves (₹6,797.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 6.00 | 6.00 | 7.00 | 6.00 | 2.00 | 12.00 | 8.00 | -603.00 | 4.00 | 14.00 | 6.00 | 5.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 12 | 11 | 16 | 3 | 3 | 3 | 3 | 7 | 7 | 9 | 4 | 2 |
Inventory Days | 620 | |||||||||||
Days Payable | 225 | |||||||||||
Cash Conversion Cycle | 407 | 11 | 16 | 3 | 3 | 3 | 3 | 7 | 7 | 9 | 4 | 2 |
Working Capital Days | 11 | -1 | -14 | -347 | -208 | -67 | -54 | -44 | -56 | -27 | -37 | -49 |
ROCE % | 23% | 20% | 25% | 20% | 26% | 33% | 28% | 22% | 26% | 37% | 50% | 46% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
DSP Natural Resources and New Energy Fund | 548,291 | 2.08 | 27.46 | 128,384 | 2025-03-20 | 327.07% |
ICICI Prudential Manufacturing Fund | 206,555 | 0.15 | 10.34 | 128,384 | 2025-03-20 | 60.89% |
Motilal Oswal Nifty Midcap 150 Index Fund | 139,111 | 0.37 | 6.97 | 128,384 | 2025-03-20 | 8.36% |
ICICI Prudential MidCap Fund | 128,384 | 0.1 | 6.43 | 128,384 | 2025-03-20 | 0% |
Nippon India ETF Nifty Midcap 150 | 127,015 | 0.37 | 6.36 | 128,384 | 2025-03-20 | -1.07% |
Nippon India Nifty Midcap 150 Index Fund | 118,283 | 0.37 | 5.92 | 128,384 | 2025-03-20 | -7.87% |
Motilal Oswal Nifty 500 Index Fund | 26,579 | 0.07 | 1.33 | 128,384 | 2025-03-20 | -79.3% |
Aditya Birla Sun Life Nifty Midcap 150 Index Fund | 20,390 | 0.37 | 1.02 | 128,384 | 2025-03-20 | -84.12% |
Motilal Oswal BSE Quality Index Fund | 9,023 | 1.48 | 0.45 | 128,384 | 2025-03-20 | -92.97% |
Motilal Oswal BSE Quality ETF | 5,687 | 1.5 | 0.28 | 128,384 | 2025-03-20 | -95.57% |
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
---|---|---|---|---|
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 |
Basic EPS (Rs.) | 18.36 | 24.88 | 22.79 | 18.89 |
Diluted EPS (Rs.) | 18.36 | 24.88 | 22.79 | 18.89 |
Cash EPS (Rs.) | 26.57 | 32.60 | 29.69 | 24.88 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 35.96 | 30.61 | 81.14 | 76.48 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 35.96 | 30.61 | 81.14 | 76.48 |
Revenue From Operations / Share (Rs.) | 68.48 | 80.71 | 69.68 | 53.56 |
PBDIT / Share (Rs.) | 34.86 | 44.70 | 41.28 | 31.93 |
PBIT / Share (Rs.) | 26.66 | 36.97 | 34.38 | 25.94 |
PBT / Share (Rs.) | 24.40 | 36.18 | 33.37 | 25.03 |
Net Profit / Share (Rs.) | 18.36 | 24.88 | 22.79 | 18.89 |
NP After MI And SOA / Share (Rs.) | 18.36 | 24.88 | 22.79 | 18.89 |
PBDIT Margin (%) | 50.91 | 55.38 | 59.24 | 59.61 |
PBIT Margin (%) | 38.92 | 45.81 | 49.33 | 48.43 |
PBT Margin (%) | 35.62 | 44.83 | 47.89 | 46.72 |
Net Profit Margin (%) | 26.81 | 30.82 | 32.70 | 35.26 |
NP After MI And SOA Margin (%) | 26.81 | 30.82 | 32.70 | 35.26 |
Return on Networth / Equity (%) | 51.06 | 81.27 | 28.08 | 24.69 |
Return on Capital Employeed (%) | 48.85 | 86.71 | 37.65 | 28.95 |
Return On Assets (%) | 22.89 | 29.63 | 21.55 | 17.45 |
Long Term Debt / Equity (X) | 0.27 | 0.11 | 0.06 | 0.13 |
Total Debt / Equity (X) | 0.55 | 0.91 | 0.08 | 0.22 |
Asset Turnover Ratio (%) | 0.83 | 0.85 | 0.00 | 0.00 |
Current Ratio (X) | 1.16 | 0.84 | 3.94 | 3.12 |
Quick Ratio (X) | 0.98 | 0.74 | 3.61 | 2.94 |
Dividend Payout Ratio (NP) (%) | 70.79 | 303.50 | 78.99 | 0.00 |
Dividend Payout Ratio (CP) (%) | 48.92 | 231.58 | 60.62 | 0.00 |
Earning Retention Ratio (%) | 29.21 | -203.50 | 21.01 | 0.00 |
Cash Earning Retention Ratio (%) | 51.08 | -131.58 | 39.38 | 0.00 |
Interest Coverage Ratio (X) | 15.42 | 56.71 | 60.14 | 34.95 |
Interest Coverage Ratio (Post Tax) (X) | 9.12 | 32.56 | 34.67 | 21.67 |
Enterprise Value (Cr.) | 131756.63 | 134390.50 | 127908.25 | 113083.00 |
EV / Net Operating Revenue (X) | 4.55 | 3.94 | 4.34 | 5.00 |
EV / EBITDA (X) | 8.94 | 7.12 | 7.33 | 8.38 |
MarketCap / Net Operating Revenue (X) | 4.27 | 3.64 | 4.44 | 5.09 |
Retention Ratios (%) | 29.20 | -203.50 | 21.00 | 0.00 |
Price / BV (X) | 8.13 | 9.59 | 3.82 | 3.57 |
Price / Net Operating Revenue (X) | 4.27 | 3.64 | 4.44 | 5.09 |
EarningsYield | 0.06 | 0.08 | 0.07 | 0.06 |
After reviewing the key financial ratios for Hindustan Zinc Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 18.36. This value is within the healthy range. It has decreased from 24.88 (Mar 23) to 18.36, marking a decrease of 6.52.
- For Diluted EPS (Rs.), as of Mar 24, the value is 18.36. This value is within the healthy range. It has decreased from 24.88 (Mar 23) to 18.36, marking a decrease of 6.52.
- For Cash EPS (Rs.), as of Mar 24, the value is 26.57. This value is within the healthy range. It has decreased from 32.60 (Mar 23) to 26.57, marking a decrease of 6.03.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 35.96. It has increased from 30.61 (Mar 23) to 35.96, marking an increase of 5.35.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 35.96. It has increased from 30.61 (Mar 23) to 35.96, marking an increase of 5.35.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 68.48. It has decreased from 80.71 (Mar 23) to 68.48, marking a decrease of 12.23.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 34.86. This value is within the healthy range. It has decreased from 44.70 (Mar 23) to 34.86, marking a decrease of 9.84.
- For PBIT / Share (Rs.), as of Mar 24, the value is 26.66. This value is within the healthy range. It has decreased from 36.97 (Mar 23) to 26.66, marking a decrease of 10.31.
- For PBT / Share (Rs.), as of Mar 24, the value is 24.40. This value is within the healthy range. It has decreased from 36.18 (Mar 23) to 24.40, marking a decrease of 11.78.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 18.36. This value is within the healthy range. It has decreased from 24.88 (Mar 23) to 18.36, marking a decrease of 6.52.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 18.36. This value is within the healthy range. It has decreased from 24.88 (Mar 23) to 18.36, marking a decrease of 6.52.
- For PBDIT Margin (%), as of Mar 24, the value is 50.91. This value is within the healthy range. It has decreased from 55.38 (Mar 23) to 50.91, marking a decrease of 4.47.
- For PBIT Margin (%), as of Mar 24, the value is 38.92. This value exceeds the healthy maximum of 20. It has decreased from 45.81 (Mar 23) to 38.92, marking a decrease of 6.89.
- For PBT Margin (%), as of Mar 24, the value is 35.62. This value is within the healthy range. It has decreased from 44.83 (Mar 23) to 35.62, marking a decrease of 9.21.
- For Net Profit Margin (%), as of Mar 24, the value is 26.81. This value exceeds the healthy maximum of 10. It has decreased from 30.82 (Mar 23) to 26.81, marking a decrease of 4.01.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 26.81. This value exceeds the healthy maximum of 20. It has decreased from 30.82 (Mar 23) to 26.81, marking a decrease of 4.01.
- For Return on Networth / Equity (%), as of Mar 24, the value is 51.06. This value is within the healthy range. It has decreased from 81.27 (Mar 23) to 51.06, marking a decrease of 30.21.
- For Return on Capital Employeed (%), as of Mar 24, the value is 48.85. This value is within the healthy range. It has decreased from 86.71 (Mar 23) to 48.85, marking a decrease of 37.86.
- For Return On Assets (%), as of Mar 24, the value is 22.89. This value is within the healthy range. It has decreased from 29.63 (Mar 23) to 22.89, marking a decrease of 6.74.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.27. This value is within the healthy range. It has increased from 0.11 (Mar 23) to 0.27, marking an increase of 0.16.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.55. This value is within the healthy range. It has decreased from 0.91 (Mar 23) to 0.55, marking a decrease of 0.36.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.83. It has decreased from 0.85 (Mar 23) to 0.83, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 24, the value is 1.16. This value is below the healthy minimum of 1.5. It has increased from 0.84 (Mar 23) to 1.16, marking an increase of 0.32.
- For Quick Ratio (X), as of Mar 24, the value is 0.98. This value is below the healthy minimum of 1. It has increased from 0.74 (Mar 23) to 0.98, marking an increase of 0.24.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 70.79. This value exceeds the healthy maximum of 50. It has decreased from 303.50 (Mar 23) to 70.79, marking a decrease of 232.71.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 48.92. This value is within the healthy range. It has decreased from 231.58 (Mar 23) to 48.92, marking a decrease of 182.66.
- For Earning Retention Ratio (%), as of Mar 24, the value is 29.21. This value is below the healthy minimum of 40. It has increased from -203.50 (Mar 23) to 29.21, marking an increase of 232.71.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 51.08. This value is within the healthy range. It has increased from -131.58 (Mar 23) to 51.08, marking an increase of 182.66.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 15.42. This value is within the healthy range. It has decreased from 56.71 (Mar 23) to 15.42, marking a decrease of 41.29.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 9.12. This value is within the healthy range. It has decreased from 32.56 (Mar 23) to 9.12, marking a decrease of 23.44.
- For Enterprise Value (Cr.), as of Mar 24, the value is 131,756.63. It has decreased from 134,390.50 (Mar 23) to 131,756.63, marking a decrease of 2,633.87.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 4.55. This value exceeds the healthy maximum of 3. It has increased from 3.94 (Mar 23) to 4.55, marking an increase of 0.61.
- For EV / EBITDA (X), as of Mar 24, the value is 8.94. This value is within the healthy range. It has increased from 7.12 (Mar 23) to 8.94, marking an increase of 1.82.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.27. This value exceeds the healthy maximum of 3. It has increased from 3.64 (Mar 23) to 4.27, marking an increase of 0.63.
- For Retention Ratios (%), as of Mar 24, the value is 29.20. This value is below the healthy minimum of 30. It has increased from -203.50 (Mar 23) to 29.20, marking an increase of 232.70.
- For Price / BV (X), as of Mar 24, the value is 8.13. This value exceeds the healthy maximum of 3. It has decreased from 9.59 (Mar 23) to 8.13, marking a decrease of 1.46.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.27. This value exceeds the healthy maximum of 3. It has increased from 3.64 (Mar 23) to 4.27, marking an increase of 0.63.
- For EarningsYield, as of Mar 24, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 23) to 0.06, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindustan Zinc Ltd:
- Net Profit Margin: 26.81%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 48.85% (Industry Average ROCE: 46.2%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 51.06% (Industry Average ROE: 55.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 9.12
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.98
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 20 (Industry average Stock P/E: 20)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.55
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 26.81%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Metals - Non Ferrous - Zinc/Zinc Alloys - Products | Yashad Bhawan, Yashadgarh, Udaipur Rajasthan 313004 | Hzl.ir@vedanta.co.in http://www.hzlindia.com |
Management | |
---|---|
Name | Position Held |
Ms. Priya Agarwal Hebbar | Non Exe. Non Ind Chairperson |
Mr. Arun Misra | WholeTime Director & CEO |
Mr. Navin Agarwal | Non Executive Director |
Mr. Akhilesh Joshi | Ind. Non-Executive Director |
Mr. Kannan Ramamirtham | Ind. Non-Executive Director |
Ms. Pallavi Joshi Bakhru | Ind. Non-Executive Director |
Dr. Veena Kumari Dermal | Non Exe. & Nominee Director |
Mrs. Nirupama Kotru | Non Exe. & Nominee Director |
Ms. Farida M Naik | Non Exe. & Nominee Director |
FAQ
What is the latest intrinsic value of Hindustan Zinc Ltd?
The latest intrinsic value of Hindustan Zinc Ltd as on 23 March 2025 is 170.25, which is 61.83% lower than the current market price of ₹446.00, indicating the stock is overvalued by 61.83%. The intrinsic value of Hindustan Zinc Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹1,88,618 Cr. and recorded a high/low of 808/290 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹6,797 Cr and total liabilities of 32,536 Cr.
What is the Market Cap of Hindustan Zinc Ltd?
The Market Cap of Hindustan Zinc Ltd is 1,88,618 Cr..
What is the current Stock Price of Hindustan Zinc Ltd as on 23 March 2025?
The current stock price of Hindustan Zinc Ltd as on 23 March 2025 is ₹446.
What is the High / Low of Hindustan Zinc Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Hindustan Zinc Ltd stocks is ₹808/290.
What is the Stock P/E of Hindustan Zinc Ltd?
The Stock P/E of Hindustan Zinc Ltd is 20.0.
What is the Book Value of Hindustan Zinc Ltd?
The Book Value of Hindustan Zinc Ltd is 18.1.
What is the Dividend Yield of Hindustan Zinc Ltd?
The Dividend Yield of Hindustan Zinc Ltd is 6.50 %.
What is the ROCE of Hindustan Zinc Ltd?
The ROCE of Hindustan Zinc Ltd is 46.2 %.
What is the ROE of Hindustan Zinc Ltd?
The ROE of Hindustan Zinc Ltd is 55.2 %.
What is the Face Value of Hindustan Zinc Ltd?
The Face Value of Hindustan Zinc Ltd is 2.00.